Covid-19

In this trial involving overweight or obese outpatients with Covid-19, investigators found that none of three repurposed drugs (metformin, ivermectin, and fluvoxamine) reduced the risk of serious disease. https://t.co/8sd6R7CDK6 pic.twitter.com/bPZ6zeuZSA

— NEJM (@NEJM) August 17, 2022

Estudo de coorte retrospectiva | Risco de parto prematuro, recém-nascido pequeno para a idade gestacional e natimorto após vacinação contra Covid-19 durante a gestação.

22 Ago, 2022 | 16:37h

Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study – The BMJ

Comunicado de imprensa: No link between COVID-19 vaccination in pregnancy and higher risk of preterm birth or stillbirth – British Medical Journal

Conteúdos relacionados:

SARS-CoV-2 infection and COVID-19 vaccination in pregnancy – Nature Reviews Immunology

Cohort Study: COVID-19 vaccination during early pregnancy was not associated with increased risk of congenital fetal anomalies.

Retrospective Cohort: A population-based study in Sweden and Norway did not find an increased risk of pregnancy complications after COVID-19 vaccination.

WHO Questions and Answers: COVID-19 vaccines and pregnancy.

COVID vaccines safely protect pregnant people: the data are in.

COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm.

A case-controlled study showed Covid-19 vaccination during early pregnancy was not associated with increased risk of first-trimester miscarriage.

Editorial: Covid-19 treatments and vaccines must be evaluated in pregnancy.

AstraZeneca vaccination not linked to reduced fertility rates and adverse birth outcomes.

Cohort study: Vaccinated pregnant patients had 90% lower risk of severe or critical Covid-19 compared with unvaccinated pregnant patients.

Two observational studies suggest spontaneous abortion is not increased following COVID-19 mRNA vaccination during pregnancy.

Study shows high effectiveness of the Pfizer mRNA COVID-19 vaccine in pregnancy.

5 Crucial Things to Know About COVID-19 Vaccines and Pregnancy.

CDC Guidance: Pregnant people should be vaccinated against COVID-19.

ACOG and SMFM Recommend COVID-19 Vaccination for Pregnant Individuals – “ACOG encourages its members to enthusiastically recommend vaccination to their patients.”

Cohort study: Pfizer/BioNTech COVID vaccine associated with 78% lower risk of Covid-19 in pregnancy.

Comentário no Twitter

No link between covid-19 vaccination in pregnancy and higher risk of preterm birth or stillbirth, finds study in @bmj_latest https://t.co/XLgFeoWVsp

Findings can help guide decision making about #covid-19 #vaccination during #pregnancy pic.twitter.com/9Pxm0Yv2Mf

— BMJ (@bmj_company) August 18, 2022

Trajetórias de risco neurológico e psiquiátrico após infecção por SARS-CoV-2: análise de estudos de coorte retrospectiva de 2 anos incluindo 1.284.437 pacientes.

22 Ago, 2022 | 16:35h

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients – The Lancet Psychiatry

Comunicado de imprensa: Increased risk of some neurological and psychiatric disorders remains two years after COVID-19 infection – University of Oxford

Comentário: Covid-19: Increased risk of some neurological and psychiatric disorders remains two years after infection, study finds – The BMJ

Comentário no Twitter

NEW—People with #COVID19 continue to face increased risks of some neurological and psychiatric conditions up to 2 years after infection, according to a study published in @TheLancetPsych: https://t.co/9fD5zMU3hE pic.twitter.com/8YhTKJ9v72

— The Lancet (@TheLancet) August 17, 2022

Diretriz | Uso de plasma convalescente de COVID-19.

22 Ago, 2022 | 16:08h

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma – Annals of Internal Medicine

Editorial: The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma – Annals of Internal Medicine

Comunicado de imprensa: The AABB releases clinical practice guidelines for the appropriate use of COVID-19 convalescent plasma – American College of Physicians

Estudo sugere que os sintomas da Covid longa afetem 1 em cada 8 pacientes.

22 Ago, 2022 | 14:59h

Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study – The Lancet

Comunicado de imprensa: Most reliable estimates to date suggest one in eight COVID-19 patients develop long COVID symptoms – Lancet

Comentários:

Long COVID symptoms affect 1 in 8 adults, some for 2 years – CIDRAP

Covid-19: One in eight adults develops long covid symptoms, study suggests – The BMJ

M-A | Período de incubação da COVID-19 causado pelas diferentes cepas do SARS-CoV-2.

Resumo de diretriz | Recomendações para tratamento medicamentoso ambulatorial de pacientes com COVID-19.

Diretriz OMS | Determinantes comportamentais e sociais da vacinação: ferramentas e diretriz prática para alcançar um alto nível de entendimento.

Estudo de coorte retrospectiva | Sintomas e fatores de risco para COVID longa em adultos não hospitalizados.

M-A | Acurácia da oximetria de pulso na medida da saturação de oxigênio conforme os níveis de pigmentação cutânea.

Estudo randomizado | Metformina, ivermectina e fluvoxamina não são benéficas para pacientes ambulatoriais obesos com Covid-19.

Estudo de coorte retrospectiva | Risco de parto prematuro, recém-nascido pequeno para a idade gestacional e natimorto após vacinação contra Covid-19 durante a gestação.

Trajetórias de risco neurológico e psiquiátrico após infecção por SARS-CoV-2: análise de estudos de coorte retrospectiva de 2 anos incluindo 1.284.437 pacientes.

Diretriz | Uso de plasma convalescente de COVID-19.

Estudo sugere que os sintomas da Covid longa afetem 1 em cada 8 pacientes.

Mantenha-se atualizado em sua especialidade

Escolha quantas especialidades quiser.